ACN
49
2
SO
55
-2
BIIB
30
-9
NWSA
78
-19
JBHT
70
2
XRAY
17
-12
ORLY
68
2
FDX
44
-7
WAT
61
-3
RL
78
-5
GS
82
2
EMC
56
-9
COF
68
3
BLK
75
3
LB
49
-33
NI
73
3
AAPL
40
-5
GME
71
6
JNPR
54
-2
LNC
50
5
ACN
49
2
SO
55
-2
BIIB
30
-9
NWSA
78
-19
JBHT
70
2
XRAY
17
-12
ORLY
68
2
FDX
44
-7
WAT
61
-3
RL
78
-5
GS
82
2
EMC
56
-9
COF
68
3
BLK
75
3
LB
49
-33
NI
73
3
AAPL
40
-5
GME
71
6
JNPR
54
-2
LNC
50
5
Financhill
Back

Intelligent Bio Solutions 10K Form

Sell
34

INBS
Intelligent Bio Solutions

Last Price:
1.93
Seasonality Move:
3.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INBS News And Ratings

See the #1 stock for the next 7 days that we like better than INBS

INBS Financial Statistics

Sales & Book Value

Annual Sales: $3.11M
Cash Flow: $-3.11M
Price / Cash Flow: 0
Annual Sales: $2.41
Price / Book: 0.93

Profitability

EPS (TTM): -39.55570
Net Income (TTM): $-10.16M
Gross Margin: $1.43M
Return on Equity: -186.3%
Return on Assets: -86.51%

Intelligent Bio Solutions Earnings Forecast

Key Intelligent Bio Solutions Financial Ratios

  • The Gross Profit Margin over the past 3 years for INBS is 45.81%.
  • The Selling, General & Administrative Expenses for INBS have been equal to 297.53% of Gross Profit Margin.
  • The Research & Development expenses have been 53.79% of Revenue.
  • The Interest Expense is -1.65% of Operating Income.
  • The Net Earning history of INBS is -326.40% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Intelligent Bio Solutions Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: INBS
Website: gbs.inc

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 1.57
Quick Ratio: 1.34

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INBS Technical Analysis vs Fundamental Analysis

Sell
34
Intelligent Bio Solutions (INBS) is a Sell

Is Intelligent Bio Solutions a Buy or a Sell?